Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective
Alexis Hure(Hunter Medical Research Institute), Andrew Searles(Hunter Medical Research Institute), Gemma A. Figtree(The University of Sydney), Martin McNamara(Sax Institute), Julie Redfern(Bond University), Catherine Kellick(New South Wales Department of Health), Rachael L. Morton(University of Sydney), Jacqui Webster(UNSW Sydney), Stephen J. Nicholls(Australian Centre for Heart Health), Garry Jennings(The University of Sydney), Shanthi Ramanathan(Hunter Medical Research Institute), Simon Deeming(Hunter Medical Research Institute), Kerry Doyle, Stephanie Blows(New South Wales Department of Health)
Cited by 3
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k